Skip to content Search the desk⌘ Ctrl K Agent Sign in M Mirum Pharmaceuticals, Inc.
M MIRM Mirum Pharmaceuticals, Inc.
M MIRM Mirum Pharmaceuticals, Inc.
Earnings When Mirum Pharmaceuticals, Inc. reports, what it reported each quarter, and how the stock took the results.
32 quarters. Sep 30, 2018 to Sep 30, 2026. USD.
Next results · Q4 2026 Projected
Feb 24, after the close
Wed, Feb 24, 2027 in 98 days
Projected from its last 8 releases. The company has not named the day yet.
Quarter Q4 2026 · Ends about Dec 31, 2026
10-K window Feb 23 – Mar 16 Quarter by quarter 3 years 5 years 10 years
Revenue Net income EPS Operating income Operating cash flow Free cash flow
Q3 2026 $ 1 8 5 . 7 2 M $185.72M +39.6% vs Q3 2025
Mirum Pharmaceuticals, Inc. · CIK 1759425 · Engraved from SEC EDGAR
Aug 5, 2026, after the close
Revenue $176.24M +37.9%
Net income -$67.23M N/M
EPS -$1.06 N/M
Revenue $159.88M +43.3%
Net income -$790.16M N/M
EPS -$13.43 N/M
Revenue $148.93M +49.8%
Net income -$5.73M N/M
EPS — —
Results day Typical move ±6.6% A typical move of 6.6% either way
Up after 6 of 12, down after 6.
+5.9% +5.7% −1.2%
When it reports
Usual day Wednesday 6 of its last 8
After quarter end 35 to 56 days
10-Q filed 35 to 38 days over its last 8
10-K filed 57 to 72 days over its last 7 ended Sep 30, 2024 · filed Nov 12, 2024 · 43 d ended Dec 31, 2024 · filed Feb 26, 2025 · 57 d ended Mar 31, 2025 · filed May 7, 2025 · 37 d ended Jun 30, 2025 · filed Aug 6, 2025 · 37 d ended Sep 30, 2025 · filed Nov 4, 2025 · 35 d FY 2026 Q3 2026 Sep 30, 2026 Nov 3, 2026 · after-hours Nov 3, 2026 34 d 10-Q $185.72M +39.6% -$0.87 +11.7% Q2 2026 Jun 30, 2026 Aug 5, 2026 · after-hours Aug 5, 2026 36 d 10-Q $176.24M +37.9% -$1.06 10.9% Q1 2026 Mar 31, 2026 May 6, 2026 · after-hours May 6, 2026 36 d 10-Q $159.88M +43.3% -$13.43 6.2%
FY 2025 Q4 2025 derived Dec 31, 2025 Feb 25, 2026 · after-hours Feb 25, 2026 56 d 10-K $148.93M +49.8% — 15.1% Q3 2025 Sep 30, 2025 Nov 4, 2025 · after-hours Nov 4, 2025 35 d 10-Q $133.01M +47.2% $0.05 1.3% Q2 2025 Jun 30, 2025 Aug 6, 2025 · after-hours Aug 6, 2025 37 d 10-Q $127.79M +64.1% -$0.12 +12.0% Q1 2025 Mar 31, 2025 May 7, 2025 · after-hours May 7, 2025 37 d 10-Q $111.59M +61.2% -$0.30 +9.8%
FY 2024 Q4 2024 derived Dec 31, 2024 Feb 26, 2025 · after-hours Feb 26, 2025 57 d 10-K $99.41M +42.9% — 7.0% Q3 2024 Sep 30, 2024 Nov 11, 2024 · after-hours Nov 12, 2024 43 d 10-Q $90.38M +89.4% -$0.30 +1.6% Q2 2024 Jun 30, 2024 Aug 7, 2024 · after-hours Aug 7, 2024 38 d 10-Q $77.88M +107.7% -$0.52 — Q1 2024 Mar 31, 2024 May 8, 2024 · after-hours May 8, 2024 38 d 10-Q $69.22M +119.1% -$0.54 —
FY 2023 Q4 2023 derived Dec 31, 2023 Feb 28, 2024 · after-hours Mar 15, 2024 75 d 10-K $69.55M +149.2% — 1.2% Q3 2023 Sep 30, 2023 Nov 2, 2023 · after-hours Nov 2, 2023 33 d 10-Q $47.73M +154.1% -$0.57 +5.7% Q2 2023 Jun 30, 2023 Aug 3, 2023 · after-hours Aug 7, 2023 38 d 10-Q $37.50M +114.5% -$1.94 +5.9% Q1 2023 Mar 31, 2023 May 4, 2023 · after-hours May 4, 2023 34 d 10-Q $31.60M +145.1% -$0.80 2.8%
FY 2022 Q4 2022 derived Dec 31, 2022 Mar 8, 2023 · after-hours Mar 8, 2023 67 d 10-K $27.91M +789.3% — — Q3 2022 Sep 30, 2022 Nov 8, 2022 · after-hours Nov 9, 2022 40 d 10-Q $18.78M +275.6% -$1.02 — Q2 2022 Jun 30, 2022 Aug 4, 2022 · after-hours Aug 4, 2022 35 d 10-Q $17.48M +58.9% -$0.84 +13.0% Q1 2022 Mar 31, 2022 May 4, 2022 · after-hours May 5, 2022 35 d 10-Q $12.89M — -$1.17 —
FY 2021 Q4 2021 derived Dec 31, 2021 Mar 9, 2022 · after-hours Mar 9, 2022 68 d 10-K $3.14M — — — Q3 2021 Sep 30, 2021 Nov 15, 2021 · after-hours Nov 15, 2021 46 d 10-Q $5.00M — -$1.55 — Q2 2021 Jun 30, 2021 Aug 5, 2021 · after-hours Aug 5, 2021 36 d 10-Q $11.00M — -$1.45 — Q1 2021 Mar 31, 2021 May 6, 2021 · after-hours May 6, 2021 36 d 10-Q $0.00 — -$1.68 —
FY 2020 Q4 2020 derived Dec 31, 2020 Mar 9, 2021 · after-hours Mar 9, 2021 68 d 10-K — — — — Q3 2020 Sep 30, 2020 Nov 11, 2020 · after-hours Nov 12, 2020 43 d 10-Q $0.00 — -$0.86 +4.7% Q2 2020 Jun 30, 2020 Aug 6, 2020 · after-hours Aug 6, 2020 37 d 10-Q $0.00 — -$0.93 +7.5% Q1 2020 Mar 31, 2020 May 7, 2020 · after-hours May 7, 2020 37 d 10-Q — — -$0.86 +5.0%
FY 2019 Q4 2019 derived Dec 31, 2019 Mar 12, 2020 · after-hours Mar 12, 2020 72 d 10-K — — — — Q3 2019 Sep 30, 2019 Nov 6, 2019 · after-hours Nov 6, 2019 37 d 10-Q — — -$0.84 — Q2 2019 Jun 30, 2019 Aug 28, 2019 · after-hours Aug 28, 2019 59 d 10-Q — — -$5.31 — Q1 2019 Mar 31, 2019 — — — — — — -$2.37 —
FY 2018 Q3 2018 Sep 30, 2018 — — — — — — -$0.14 —
Earlier years, FY 2018 to FY 2023 The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
10-Q
May 6, 2026
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
Year over year, last four quarters
Revenue $148.93M Revenue, change from a year earlier: Q3 2026 +39.6%, Q2 2026 +37.9%, Q1 2026 +43.3%, Q4 2025 +49.8% +49.8% +43.3% +37.9% +39.6%
Net income -$5.73M Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m n/m n/m n/m n/m
EPS — EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m n/m n/m n/m n/m +11.7% by the close of Nov 4
Thaler Research Engraved from SEC EDGAR © 2026 Thaler. All rights reserved. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
10.9% by the close of Aug 6
ended Dec 31, 2025 · filed Feb 25, 2026 · 56 d ended Mar 31, 2026 · filed May 6, 2026 · 36 d ended Jun 30, 2026 · filed Aug 5, 2026 · 36 d ended Sep 30, 2026 · filed Nov 3, 2026 · 34 d window Feb 23 – Mar 16 · projected The stock’s move from the last close before each release to the first close after it, over the last 12 releases. Largest: −15.1% after Q4 2025.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Provenance Data status and checks